JVS-100

N/A

Report date: 2023/12/08 13:38:34

Base Information

Drug NameJVS-100
Drug Alias NameJVS-100SRX-100ACRX-100GP-51801GP51801
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionLeukocytes stimulantsC-X-C motif chemokine receptor 4 stimulantsGene transference +[5] 
TargetsC-X-C motif chemokine receptor 4C-X-C motif chemokine ligand 12
Therapy Area/IndicationsSurgical WoundIschemiaPeripheral Arterial Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndiaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCleveland Clinic
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesNanjing Jiqun Biotechnology Co Ltd
Inactive CompaniesJuventas Therapeutics Inc
Active IndicationsSurgical Wound
Inactive IndicationsIschemiaPeripheral Arterial DiseaseHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A